Dom Development S.A. (DOM)
Warsaw Stock Exchange · Poland · prices in PLN · close of 22 Oct 2026
Key indicators
| Last close | PLN 240.00 |
|---|---|
| 52-week range | 220.00 – 284.50 |
| Return, 1 month / 3 months | +5.3% / −7.7% |
| Return, 1 year / 3 years | +4.5% / +85.2% |
| Trend | Below its 200-day average |
| RSI (14) | 55 |
| Volatility (1 year) | 23.9% |
| Worst drawdown (1 year) | -20.7% |
| Average daily value traded | 2.51M PLN |
| Dividend yield | 5.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Dom Development is a Polish residential property developer based in Warsaw. The company builds and sells apartments and houses, mostly on housing estates in the Polish capital and other cities, and its customers are mainly individual homebuyers. Its work covers buying land, designing and constructing residential buildings, and marketing and handing over completed units to buyers. The company also provides related services to residents of the estates it develops.
Dom Development S.A. trades under the code DOM on the Warsaw Stock Exchange in Poland, with its price quoted in Polish zloty (PLN). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Dom Development S.A. (DOM) trades on the Warsaw Stock Exchange in Poland. It last closed at PLN 240.00 on 22 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 132 of 580 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.5% and over the last three months it fell 7.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Warsaw Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.5% | ||
| From 52-week high | -14.3% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -7.7% | ||
| 6-month return | -1.7% | ||
| 12-month return, skipping the last month | -0.7% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.7% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 2.51M PLN | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.8% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +2.1% |
|---|---|
| 1 month | +5.3% |
| 3 months | −7.7% |
| 6 months | −1.7% |
| 1 year | +4.5% |
| 3 years | +85.2% |
| 5 years | +152.5% |
Signals
| 50-day / 200-day average | 238.05 / 246.11 |
|---|---|
| Golden / death cross (60 days) | Death, 22 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.05 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Jun 2026 | PLN 7.0000 |
| 1 Dec 2025 | PLN 7.0000 |
| 24 Jun 2025 | PLN 7.0000 |
| 11 Dec 2024 | PLN 6.0000 |
| 25 Jun 2024 | PLN 6.5000 |
| 11 Dec 2023 | PLN 5.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Warsaw Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.